EARTH SCIENCE TECH, INC. ETST currently holds three wholly owned subsidiaries:
2022 Highlights:
- ETST retired approximately
$1,118,334 of its debt, 47% of the Company’s liabilities subsequently from the period endingSeptember 30, 2022 , reported 10-Q and will be reflected in the third quarter fiscal 2023 ended period endingDecember 31 , 2022’s 10-Q.
(view filed 8-K)
- ETST consummated mergers with its 2 candidates, RxCompound and Peaks, from its
November 7, 2021 , executed agreement, subsequently amended onNovember 8, 2022 . Both RxCompound and Peaks have approximately 75 days from the date of consummation to complete their respective PCAOB audits to transition their books and operations into the Company.
(view filed 8-K)
- ETST secured funding within the month of
October 2022 for operations up to the date the Company achieves cash flow positive status.
(view filed 8-K)
- RxCompound’s hazardous compounding room commenced operations within the month of
December 2022 improving sales by increasing product offerings. - ETST received Peaks’ audited financials on
December 29, 2022 , pursuant to the consummation datedNovember 8, 2022 .
(view filed 8-K)
- RxCompound expanded its dispensing network from 2 states,
Florida , andNew York , to 6, by obtaining licenses in the states ofColorado ,New Jersey ,Rhode Island , andArizona . - Peaks has commenced testing of its website’s upgrades after successfully launching the first version in
June 2022 . The updated site will offer generic versions of both Cialis and Viagra along with other compounded varieties of Tadalafil and Sildenafil, including its popular Tadalafil gummies. - RxCompound revamped its website within the month of
December 2022 .
About
To learn more, please visit: www.EarthScienceTech.com
About
To learn more please visit: www.RxCompoundStore.com
About
To learn more please visit: www.PeaksCurative.com
SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, listing on the CSE, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.
Company Contact:
CEO & Director
(786) 375-7281
nick@earthsciencetech.com
2023 GlobeNewswire, Inc., source
